Search results
Pfizer, Flagship to focus on obesity drugs under $100M collaboration - Boston Business Journal
The Business Journals· 3 days agoAlmost a year after Cambridge’s Flagship Pioneering and Pfizer Inc. announced a partnership to...
Lilly’s Weight-Loss Drug Is a Huge Hit. Its CEO Wants to Replace It ASAP.
The Wall Street Journal· 2 days agoThus far the sprint has been as fast as drug development can be, mainly between Lilly and Novo...
Pfizer, Flagship name first target for multibillion-dollar collaboration: obesity
FierceBiotech· 3 days agoPfizer and Flagship Pioneering have settled on the first target for their billion-dollar,...
Flagship Pioneering and ProFound link for obesity therapies
Pharmaceutical Technology via Yahoo Finance· 2 days agoProFound Therapeutics CEO and Flagship Pioneering CEO-partner John Lepore stated: “We are thrilled...
Moderna’s New Flu-COVID Combi mRNA Vaccine Outperforms Separate Shots In Trials
IFLScience· 4 days agoModerna became a household name thanks to the success of its mRNA vaccine against COVID-19. Along...
Pentagon Launched Secret Anti-Vax Campaign To Discredit China During COVID Pandemic, Report Says
Forbes· 2 days agoThe Department of Defense surreptitiously operated an anti-vaccine campaign aimed at Chinese...
Republicans, including detractors, embrace Trump in return to Washington after Jan. 6
ABC News· 2 days agoDonald Trump made a rare appearance in Washington on Thursday to lay out his second-term agenda to...
Five things: What's up at MassDevelopment, MLSC, rooftop gardens and a tribute to Marvelous Marvin...
The Business Journals· 2 days agoGreg Ryan reports on the rough state of affairs at economic development agency MassDevelopment, whose president and CEO, Dan Rivera, departed abruptly in late April. Hannah ...
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC New York· 5 days agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...
Regenxbio CEO to step down after 15 years
BioPharma Dive via Yahoo Finance· 3 days agoKenneth Mills will become chair of the gene therapy developer's board while Curran Simpson, the current chief operating officer, will take his place as...